Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations

被引:0
|
作者
Thomas Glaab
Claus Vogelmeier
Roland Buhl
机构
[1] University Hospital,Pulmonary Department
[2] Johannes Gutenberg-University,Department of Pneumology
[3] University Hospital Giessen and Marburg,undefined
来源
Respiratory Research | / 11卷
关键词
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Exercise Capacity; Functional Residual Capacity; Severe Chronic Obstructive Pulmonary Disease;
D O I
暂无
中图分类号
学科分类号
摘要
Current methods for assessing clinical outcomes in COPD mainly rely on physiological tests combined with the use of questionnaires. The present review considers commonly used outcome measures such as lung function, health status, exercise capacity and physical activity, dyspnoea, exacerbations, the multi-dimensional BODE score, and mortality. Based on current published data, we provide a concise overview of the principles, strengths and weaknesses, and discuss open questions related to each methodology. Reviewed is the current set of markers for measuring clinically relevant outcomes with particular emphasis on their limitations and opportunities that should be recognized when assessing and interpreting their use in clinical trials of COPD.
引用
收藏
相关论文
共 50 条
  • [21] Depression and chronic obstructive pulmonary disease (COPD). Impact on survival
    Stage, KB
    Middelboe, T
    Pisinger, C
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (04) : 320 - 323
  • [22] The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD)
    Green, Clara E.
    Turner, Alice M.
    RESPIRATORY RESEARCH, 2017, 18
  • [23] Impact of chronic obstructive pulmonary disease (COPD) on attention functions
    Klein, M.
    Gauggel, S.
    Sachs, G.
    Pohl, W.
    RESPIRATORY MEDICINE, 2010, 104 (01) : 52 - 60
  • [24] Evaluation of Patient Preference and Willingness to Pay for Attributes of Maintenance Medication for Chronic Obstructive Pulmonary Disease (COPD)
    Ariane K. Kawata
    Leah Kleinman
    Gale Harding
    Sulabha Ramachandran
    The Patient - Patient-Centered Outcomes Research, 2014, 7 : 413 - 426
  • [25] Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany
    Florian Hofer
    Dmitrij Achelrod
    Tom Stargardt
    Applied Health Economics and Health Policy, 2016, 14 : 691 - 701
  • [26] An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
    Boyd, G
    Morice, AH
    Pounsford, JC
    Siebert, M
    Peslis, N
    Crawford, C
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (04) : 815 - 821
  • [27] The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD)
    Clara E. Green
    Alice M. Turner
    Respiratory Research, 18
  • [28] Postural deviations in individuals with chronic obstructive pulmonary disease (COPD)
    Lee, Annemarie L.
    Goldstein, Roger S.
    Chan, Christen
    Rhim, Matthew
    Zabjek, Karl
    Brooks, Dina
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2018, 2 (02) : 61 - 68
  • [29] Extra-Pulmonary Aspects of Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
    Viglino, D.
    Maignan, M.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2020, 10 (03): : 139 - 145
  • [30] Phenotyping provides potential for a personalized approach in patients with chronic obstructive pulmonary disease (COPD)
    Adis Medical Writers
    Drugs & Therapy Perspectives, 2015, 31 (3) : 89 - 92